Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $374B |
| FY2017, ended Dec 31, 2017 | $354B |
| FY2018, ended Dec 31, 2018 | $289B |
| FY2019, ended Dec 31, 2019 | $295B |
| FY2020, ended Dec 31, 2020 | $175B |
| FY2021, ended Dec 31, 2021 | $259B |
| FY2022, ended Dec 31, 2022 | $449B |
| FY2023, ended Dec 31, 2023 | $397B |
| FY2024, ended Dec 31, 2024 | $467B |
| FY2025, ended Dec 31, 2025 | $501B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $562B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $201B |
| FY2017, ended Dec 31, 2017 | $244B |
| FY2018, ended Dec 31, 2018 | $290B |
| FY2019, ended Dec 31, 2019 | $265B |
| FY2020, ended Dec 31, 2020 | $182B |
| FY2021, ended Dec 31, 2021 | $286B |
| FY2022, ended Dec 31, 2022 | $414B |
| FY2023, ended Dec 31, 2023 | $345B |
| FY2024, ended Dec 31, 2024 | $350B |
| FY2025, ended Dec 31, 2025 | $332B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $369B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $7.84B | $5.92B |
| FY2017, ended Dec 31, 2017 | $19.7B | $14.7B |
| FY2018, ended Dec 31, 2018 | $20.8B | $16.4B |
| FY2019, ended Dec 31, 2019 | $14.3B | $5.36B |
| FY2020, ended Dec 31, 2020 | −$22.4B | −$2.61B |
| FY2021, ended Dec 31, 2021 | $23.0B | $36.1B |
| FY2022, ended Dec 31, 2022 | $55.7B | $58.4B |
| FY2023, ended Dec 31, 2023 | $36.0B | $33.5B |
| FY2024, ended Dec 31, 2024 | $33.7B | $30.7B |
| FY2025, ended Dec 31, 2025 | $28.8B | $23.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $32.8B | $30.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.66B |
| FY2017, ended Dec 31, 2017 | $3.18B |
| FY2018, ended Dec 31, 2018 | $3.04B |
| FY2019, ended Dec 31, 2019 | $3.09B |
| FY2020, ended Dec 31, 2020 | $4.36B |
| FY2021, ended Dec 31, 2021 | $6.80B |
| FY2022, ended Dec 31, 2022 | $29.6B |
| FY2023, ended Dec 31, 2023 | $31.5B |
| FY2024, ended Dec 31, 2024 | $23.0B |
| FY2025, ended Dec 31, 2025 | $10.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.6B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $41.5B |
| FY2017, ended Dec 31, 2017 | $41.0B |
| FY2018, ended Dec 31, 2018 | $37.8B |
| FY2019, ended Dec 31, 2019 | $46.9B |
| FY2020, ended Dec 31, 2020 | $67.6B |
| FY2021, ended Dec 31, 2021 | $47.7B |
| FY2022, ended Dec 31, 2022 | $41.2B |
| FY2023, ended Dec 31, 2023 | $41.6B |
| FY2024, ended Dec 31, 2024 | $41.7B |
| FY2025, ended Dec 31, 2025 | $43.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $42.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 0.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 4.15B |
| FY2017, ended Dec 31, 2017 | 4.24B |
| FY2018, ended Dec 31, 2018 | 4.23B |
| FY2019, ended Dec 31, 2019 | 4.23B |
| FY2020, ended Dec 31, 2020 | 4.23B |
| FY2021, ended Dec 31, 2021 | 4.23B |
| FY2022, ended Dec 31, 2022 | 4.07B |
| FY2023, ended Dec 31, 2023 | 3.97B |
| FY2024, ended Dec 31, 2024 | 4.34B |
| FY2025, ended Dec 31, 2025 | 4.17B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 4.11B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Used in acquisitions |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $977M | — |
| FY2017, ended Dec 31, 2017 | $747M | — |
| FY2018, ended Dec 31, 2018 | $626M | — |
| FY2019, ended Dec 31, 2019 | $594M | — |
| FY2020, ended Dec 31, 2020 | $405M | — |
| FY2021, ended Dec 31, 2021 | $155M | — |
| FY2022, ended Dec 31, 2022 | $15.2B | — |
| FY2023, ended Dec 31, 2023 | $17.7B | $4.84B |
| FY2024, ended Dec 31, 2024 | $19.6B | $63.4B |
| FY2025, ended Dec 31, 2025 | $20.3B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $20.5B | — |
Valuation
At current price- Market Cap
- $740B
- P/E
- 22.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.0×
- Price / Book
- 2.9×
- EV / EBITDA
- 10.3×
Growth
Trailing 12 months- Revenue (TTM)
- $369B
- Revenue Growth YoY
- 9.1%
- Revenue CAGR 3Y
- −7.0%
- Revenue CAGR 5Y
- 12.9%
- EPS Growth YoY
- 10.4%
- Net Income Growth YoY
- 5.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 12.3%
- Net Margin
- 8.9%
- FCF Margin
- 8.3%
- Return on Equity
- 12.6%
Earnings
Trailing 12 months- Net Income
- $32.8B
- EPS (diluted)
- $7.77
- EBITDA
- $75.0B
- Operating Income
- $45.4B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $10.6B
- Total Debt
- $42.4B
- Net Debt
- $31.8B
- Total Assets
- $464B
- Total Liabilities
- $198B
- Shareholders' Equity
- $259B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $59.7B
- Capital Expenditure
- $29.2B
- Free Cash Flow
- $30.6B
Dividends and risk
Last 12 months- Dividend Yield
- 2.3%
- Dividend / Share
- $4.12
- Beta (5Y)
- 0.22
Every ratio is calculated from the company’s reported figures.